Shovon Ashraf Ph.D.

Shovon Ashraf Ph.D.

Goodwin

Contact
View Bio
RSS

Latest Posts › New Guidance

Share:

The USPTO’s Increasing Focus on FDA Submissions and the Duty of Disclosure

​​​​​​​The United States Patent and Trademark Office (USPTO) imposes a Duty of Disclosure, Candor and Good Faith (Duty of Disclosure) on all individuals associated with the filing and prosecution of a patent application...more

8/18/2022  /  Disclosure Requirements , Food and Drug Administration (FDA) , Good Faith , New Guidance , Patent Applications , Patent Examinations , Pharmaceutical Patents , Proposed Legislation , USPTO
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide